No Data
No Data
X4 Pharmaceuticals, Inc. (XFOR) Q2 2024 Earnings Call Transcript
X4 Pharmaceuticals Unveils Corporate Presentation for Investors
X4 Pharmaceuticals (XFOR) Gets a Buy From Piper Sandler
Buy Rating Affirmed on X4 Pharmaceuticals: A Comprehensive Analysis of Financial Stability and Drug Development Progress
10-Q: Q2 2024 Earnings Report
X4 Pharmaceuticals 2Q Rev $563,000 >XFOR
No Data